Your browser doesn't support javascript.
loading
A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.
Chan, Stephen L; Yeo, Winnie; Mo, Frankie; Chan, Anthony W H; Koh, Jane; Li, Leung; Hui, Edwin P; Chong, Charing C N; Lai, Paul B S; Mok, Tony S K; Yu, Simon C H.
  • Chan SL; State Key Laboratory of Oncology in South China, Hong Kong.
  • Yeo W; Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
  • Mo F; Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.
  • Chan AWH; State Key Laboratory of Oncology in South China, Hong Kong.
  • Koh J; Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
  • Li L; State Key Laboratory of Oncology in South China, Hong Kong.
  • Hui EP; Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
  • Chong CCN; State Key Laboratory of Oncology in South China, Hong Kong.
  • Lai PBS; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong.
  • Mok TSK; Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
  • Yu SCH; Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.
Cancer ; 123(20): 3977-3985, 2017 Oct 15.
Article en En | MEDLINE | ID: mdl-28640364
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Inhibidores de Proteínas Quinasas / Imidazoles / Indazoles / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Inhibidores de Proteínas Quinasas / Imidazoles / Indazoles / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2017 Tipo del documento: Article